The purpose of this platform is to develop a well characterized dataset of individuals with mood disorders who may be invited to participate in treatment studies informed by the baseline data collected. The baseline clinical and neurobiological data that is collected through the ENABLE platform will be added to a database to help characterize relevant biomarkers across the spectrum of mood disorder symptoms.
Eligibility Criteria
- Age Range: 16 years of age or old
- Meet criteria for bipolar or depressive disorders
- Fluent in English
What does the study involve?
- Number of contacts: 1-3
- Format of study: In-person
- Compensation offered? Yes
Investigator(s): Dr. Lena Quilty
Full Study Title: Enabling Neuroscience research Approaches for Brain, feeLings and Emotions (ENABLE): An Innovative Platform for Clinical Trials in Mood Disorders
Contact Information:
E-mail: enable@camh.ca
REB number: 014/2024
REB Approval Expiry Date: July 31, 2026
PLEASE NOTE:
- Research staff cannot give medical advice over the phone or via email.
- If you have specific questions regarding your health care, please contact your family physician.
- We regret that not everyone screened for a study will be eligible to participate
- For more information about other treatment options for mental illness or addiction offered by CAMH, visit www.camh.ca or call 416-535-8501.